Efficacy of fluconazole for the treatment of onychomycosis

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1684-1691

  Brown, Sherrill J ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

Dermatophyte; Fluconazole; Onychomycosis

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CHEMICAL HEPATITIS; CLINICAL TRIAL; DERMATOMYCOSIS; DERMATOPHYTE; DIARRHEA; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; FOLLOW UP; GASTROINTESTINAL PAIN; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS; HUMAN; NAUSEA; ONYCHOMYCOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TOENAIL ONYCHOMYCOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUCONAZOLE; HUMANS; ITRACONAZOLE; NAPHTHALENES; ONYCHOMYCOSIS; TREATMENT OUTCOME;

EID: 70449489662     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M165     Document Type: Review

References (28)

1. Nelson MM, Martin AG, Heffernan MP. Superficial fungal infections: dermatophytosis, onychomycosis, tinea nigra, piedra. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2003:1989-2005.
2. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003;148:402-410
3. Kaur R, Kashyap B, Bhalla P. Onychomycosis - epidemiology, diagnosis and management. Indian J Med Microbiol 2008;26:108-116
4. Hay RJ. Dermatophytosis and other superficial mycoses. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2005:3051-3062
5. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008;166:335-352
6. Kaviarasan PK, Jaisankar TJ, Thappa DM, Sujatha S. Clinical variations in dermatophytosis in HIV infected patients. Indian J Dermatol Venereol Leprol 2002;68:213-216 (Pubitemid 44057930)
7. Nolting S, Brautigam M, Weiding G. Terbinafine in onychomycosis with involvement by non-dermatophytic fungi. Br J Dermatol 1994;130(suppl 43):16-21. (Pubitemid 24203329)
8. Niewerth M, Korting HC. Management of onychomycosis. Drugs 1999;58:283-296
9. Palmeri A, Pichini S, Pacifici R, Zuccaro P, Lopez A. Drugs in nails: physiology, pharmacokinetics and forensic toxicology. Clin Pharmacokinet 2000;38:95-110. (Pubitemid 30122115)
10. Product information. Sporanox (itraconazole). Titusville, NJ: Janssen, April 2008.
11. Product information. Lamisil (terbinafine). East Hanover, NJ: Novartis Pharmaceuticals Corp., November 2005.
12. Product information. Diflucan (fluconazole). New York: Pfizer Inc., March 2008.
13. Barchiesi F, Silvestri C, Arzeni D, et al. In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol 2009;47:321-326
14. Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007;45:1735-1745
15. Savin RC, Drake L, Babel D, et al. Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail. J Am Acad Dermatol 1998;38:S110-6.
16. Rich P, Scher RK, Breneman D, et al. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail. J Am Acad Dermatol 1998;38:S103-9.
17. Debruyne D, Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet 2001;40:441-472
18. Havu V, Brandt H, Heikkilä H, et al. Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison. Br J Dermatol 1999;140:96-101. (Pubitemid 29074538)
19. Scher RK, Breneman D, Rich P, et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol 1998;38:S77-86.
20. Drake L, Babel D, Stewart DM, et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J Am Acad Dermatol 1998;38:S87-94.
21. Ling MR, Swinyer LJ, Jarratt MT, et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol 1998;38:S95-102.
22. Gupta AK. Treatment of dermatophyte toenail onychomycosis in the United States: a pharmacoeconomic analysis. J Am Podiatr Med Assoc 2002;92:272-286
23. Chen X, Hiruma M, Shiraki Y, Ogawa H. Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis. Jpn J Infect Dis 2004;57:260-263
24. Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 2005;28:1805-1808.
25. Arca E, Tafltan HB, Akar A, Kurumlu Z, Gür AR. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis. J Dermatol Treat 2002;13:3-9. (Pubitemid 34163692)
26. Havu V, Heikkilä H, Kuokkanen K, et al. A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis. Br J Dermatol 2000;142:97-102. (Pubitemid 30074477)
27. Gupta AK, Gregurek-Novak T. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Dermatology 2001;202:235-238
28. Chang CH, Young-Xu Y, Kurth T, Orav JE, Chan AK. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med 2007;120:791-798 (Pubitemid 47313346)